Learn your genetic risk for the most common hereditary cancers.

Similar documents
WHAT IS A GENE? CHROMOSOME DNA PROTEIN. A gene is made up of DNA. It carries instructions to make proteins.

A Patient s Guide to Hereditary Cancer. Is Hereditary Cancer Testing Right for You?

WHAT IS A GENE? CHROMOSOME DNA PROTEIN. A gene is made up of DNA. It carries instructions to make proteins.

The Next Generation of Hereditary Cancer Testing

GYNplus: A Genetic Test for Hereditary Ovarian and/or Uterine Cancer

GYNplus. genetic testing for hereditary ovarian and/or uterine cancer

patient guide CancerNext genetic testing for hereditary cancer Because knowing your risk can mean early detection and prevention

The benefit of. knowing. Genetic testing for hereditary cancer. A patient support guide

Genetic testing for hereditary cancer

A pathogenic mutation was identified in the BRCA1 gene.

CentoCancer STRIVE FOR THE MOST COMPLETE INFORMATION

Be Ready Pack Learn more about how Myriad myrisk is revolutionizing hereditary cancer testing.

patient guide CancerNext-Expanded genetic testing for hereditary cancer Because knowing your risk can mean early detection and prevention

A guide to genetic testing for hereditary cancers

BRCAplus. genetic testing for hereditary breast cancer

Why Test for Hereditary Cancer in Preventive Care?

Germline Multigene Panel Testing in Oncology: Genetic Counseling Perspective

OvaNext. patient guide. genetic testing for hereditary breast, ovarian, and uterine cancer

Are you at risk of Hereditary Cancer? Your Guide to the Answers

Genetic Risk Assessment for Cancer

Genetic testing and pancreatic disease

Myriad Financial Assistance Program (MFAP)

The Role of genetic Testing for Inherited Prostate Cancer Risk

Understanding Your Positive Result. A guide to understanding your risk and taking action

patient guide BreastNext genetic testing for hereditary breast cancer Because knowing your risk can mean early detection and prevention

Hereditary Cancer Products

Assessment and Management of Genetic Predisposition to Breast Cancer. Dr Munaza Ahmed Consultant Clinical Geneticist 2/7/18

patient guide ProstateNext genetic testing for hereditary prostate cancer Because knowing your risk can mean early detection and prevention

patient guide PancNext genetic testing for hereditary pancreatic c a ncer Because knowing your risk can mean early detection and prevention

Genetic Testing for Familial Gastrointestinal Cancer Syndromes. C. Richard Boland, MD La Jolla, CA January 21, 2017

Germline Testing for Hereditary Cancer with Multigene Panel

Genetics & Precision Medicine Cancer Care

Use of panel tests in place of single gene tests in the cancer genetics clinic

6/8/17. Genetics 101. Professor, College of Medicine. President & Chief Medical Officer. Hereditary Breast and Ovarian Cancer 2017

Cancer Survivorship Symposium Cancer and Heredity January 16, Jeanne P. Homer, MS Licensed Certified Genetic Counselor

Genetic Testing for Lynch Syndrome

CASE STUDY. Germline Cancer Testing in A Proband: Extension of Benefits to Unaffected Family Members. Introduction. Patient Profile.

Genetic Testing for BRCA1 and BRCA2 Genes

Genetic Risk Assessment for Cancer

Corporate Medical Policy

Carol Christianson, MS, CGC Genetic Counselor West Michigan Cancer Center

Genetic Determinants, Risk Assessment and Management

Genetic Testing: who, what, why?

TGL clinical User Guide

COLON CANCER & GENETICS VERMONT COLORECTAL CANCER SUMMIT NOVEMBER 15, 2014

Prior Authorization. Additional Information:

BowelGene. How do I know if I am at risk? Families with hereditary bowel cancer generally show one or more of the following clues:

11/29/2017. Genetics and Cancer ERICA L SILVER, MS, LCGC GENETIC COUNSELOR. Genetics 101. Transcription vs Translation

patient guide MelanomaNext genetic testing for hereditary melanoma Because knowing your risk can mean early detection and prevention

Yes when meets criteria below. Dean Health Plan covers when Medicare also covers the benefit.

Objectives. Genetics in Cancer Treatment and Prevention. Genes

Proactive Patient Paves the Way for Genetic Testing of Eight Family Members

OncoGeneDx Test Requisition Form

GHUK BowelGene_2017.qxp_Layout 1 22/02/ :22 Page 3 BowelGene

DNA Genetic Cancer Risk Test. Test Report

Versus. Cancer genomics Competitive Analysis

Expert Interview: Inherited Susceptibility to Cancer with Dr. Nicoleta Voian

NEWSLETTER. Summer Test All Baby Boomers for Hepatitis C, Experts Say

MOLECULAR SERVICES. mlabs.umich.edu

Genetic Cancer Susceptibility Panels Using Next Generation Sequencing

patient guide RenalNext genetic testing for hereditary kidney cancer Because knowing your risk can mean early detection and prevention

Family Assessment. Objectives. Comprehensive Family History Important Inexpensive Underutilized genetic tool

Multiple gene sequencing for risk assessment in patients with early-onset or familial breast cancer

MSI positive MSI negative

Medical Policy An independent licensee of the Blue Cross Blue Shield Association

GEN ETICS AN D GEN OM ICS IN CANCER PREVENTION AN D TREATM EN T. Robert Nathan Slotnick MD PhD Director, Medical Genetics and Genomics

Genetic Testing for BRCA1 and BRCA2 Genes

Incorporating Hereditary Cancer Risk Assessment into Your Practice

Populations Interventions Comparators Outcomes Individuals: With a personal and/or family history suggesting an inherited cancer syndrome

Hereditary Cancer Risk Assessment for Gynecological Cancers. FarrNezhatMD.com

Hereditary Cancer. Genetic Testing Services. The GeneDx Experience

Genetic Cancer Susceptibility Panels Using Next Generation Sequencing

OncoGeneDx Test Requisition Form

NGS for Cancer Predisposition

Genetics and Cancer Care. Cynthia Forster-Gibson, MD, PhD and Loren Mackay- Loder, MSc Genetics Program, THP

Hereditary Aspects of Pancreatic Cancer

Information for You and Your Family

ProstateGene What is hereditary prostate cancer? What are genes?

PROVIDER POLICIES & PROCEDURES

CASE STUDY. Mutation-Specific Testing: Eligibility for PARP Inhibitor Therapy Established. Introduction. Patient Profile.

Clinical Cancer Genetics

patient guide BrainTumorNext genetic testing for hereditary brain tumors Because knowing your risk can mean early detection and prevention

GENETIC TESTING FOR HEREDITARY CANCER

ProstateGene GeneHealth UK

Management of BRCA Positive Breast Cancer. Archana Ganaraj, MD February 17, 2018 UPDATE ON WOMEN S HEALTH

MEDICAL POLICY Genetic Testing for Breast and Ovarian Cancers

Managing Moderate Penetrance

Multigene Panel Testing for Hereditary Cancer Risk

CASE STUDY. Germline Test for Mother and Follow up Testing for Daughter: Assessment of Hereditary Cancer Risk. Introduction.

Hereditary Breast and Ovarian Cancer Rebecca Sutphen, MD, FACMG

Schedule of Accreditation issued by United Kingdom Accreditation Service 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK

ריבוי פוליפים בחולה צעיר. איתי מזאה MD PhD

Hereditary Cancer Update Strengthening Linkages Workshop April 22, 2017

Genetic Testing Today: What Genes Can Tell Us. Living Beyond Breast Cancer Conference Kara N. Maxwell, MD, PhD University of Pennsylvania

TumorNext-HRD with OvaNext: Paired Germline and Tumor Analyses of Genes Involved in

Enabling Personalized

How common are mutations in the MSH2 gene? 1. Mutations that cause Lynch syndrome are rare found in approximately 1 in 370 individuals.

Transcription:

Learn your genetic risk for the most common hereditary cancers. color.com

Color analyzes 30 genes including BRCA1 and BRCA2 to help women and men understand their risk for the most common hereditary cancers, including breast, ovarian, colorectal, and pancreatic cancer. Why get genetic testing? Personalized screening and prevention 10-15% of most cancers are due to inherited genetic mutations. 1-3 Knowing you have a mutation that increases your risk allows you and your healthcare provider to create a personalized plan designed to prevent or detect cancers like breast, ovarian, colorectal, and pancreatic at an earlier or more treatable stage. Relatives may benefit too Knowing you have a genetic mutation may be important information to share with your relatives. For example, if a man carries a mutation in BRCA1, each of his children has a 50% chance of carrying the same mutation. How mutations impact risk 70-100% 81% 54% 10% BRCA1 1% BRCA1 4-5% APC Breast cancer Ovarian cancer Colorectal cancer Average US lifetime risk 4 5, 6, 7 Risk by age 80 with mutation

The Color experience Personalized test results Complimentary genetic counseling Clear results about the presence or absence of any mutations that increase your risk for developing cancer Personalized cancer risk information to discuss with your healthcare provider Cancer screening guidelines published by experts Info on how your results might impact your family Color offers you and your healthcare provider access to our team of board-certified genetic counselors to answer any questions you may have about your results. Coordination with your healthcare providers You will be able to access your results online at color.com and a copy will be shared directly with your provider. Simplified billing and insurance Our transparent process allows you access to the lowest estimated payment option available, whether it is our $249 self-pay price or through coverage by your insurance company.

Genes covered Gene Breast Ovarian Uterine BRCA1 BRCA2 Colorectal Melanoma Pancreatic MLH1 MSH2 MSH6 PMS2*** EPCAM** APC MUTYH MITF** BAP1 CDKN2A Stomach Prostate* Color s $249 self-pay test, includes complimentary genetic counseling. Your privacy is our priority We take your privacy very seriously and only collect the information that is needed to provide you with a high-quality experience. Color complies with the Health Insurance Portability and Accountability Act (HIPAA) regarding protected health information. Clinical-grade genetic testing Color s laboratory has been accredited by the College of American Pathologists (CAP) and has Clinical Laboratory Improvement Amendments (CLIA) certification. The Color Test showed >99% accuracy in multiple validation studies. CDK4** TP53 PTEN STK11 CDH1 BMPR1A SMAD4 GREM1** POLD1** POLE** PALB2 CHEK2 ATM NBN BARD1 BRIP1 RAD51C RAD51D References 1 Tung N et al. Cancer 121(1), 2015. 2 Pal T et al. Cancer 104(12), 2005. 3 Risch HA et al. The American Journal of Human Genetics 68(3), 2001. 4 SEER Stat Fact Sheets: Breast Cancer. National Cancer Institute. Accessed January 2016. 5 King MC et al. Science 302(5645), 2003. 6 Jasperson KW, Tuohy TM, Neklason DW, Burt RW. Hereditary and familial colon cancer. Gastro. 2010 Jun; 138(6):2044-58. 7 Burt RW, et al. Genetic testing and phenotype in a large kindred with attenuated familial adenomatous polyposis. Gastro. 2004 Aug; 127(2):444-51. * Please note that research and screening guidelines on genes associated with hereditary prostate cancer are still in their early stages. It is part of the Color service to keep you updated if any information related to your results changes. ** Only positions known to impact cancer risk analyzed: CDK4: only chr12:g.58145429-58145431 (codon 24) analyzed, EPCAM: only large deletions and duplications including 3 end of the gene analyzed, GREM1: only duplications in the upstream regulatory region analyzed, MITF: only chr3:g.70014091 (including c.952g>a) analyzed, POLD1: only chr19:g.50909713 (including c.1433g>a) analyzed, POLE: only chr12:g.133250250 (including c.1270c>g) analyzed. *** PMS2: Exons 12-15 not analyzed.

color.com (844) 352-6567 (US) +1 650-651-7130 (Global) @Color C2.0PAB 06/17 Color support@color.com